Search

everythinglearnresearchcommunity

for

Search:↓

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Young women with high male hormone levels or PCOS often feel more psychological distress and have a lower quality of life.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Diagnosing PCOS in teenagers is challenging and should use strict criteria to avoid misdiagnosis and unnecessary worry.

Over a third of women thought to have non-classical congenital adrenal hyperplasia didn't have it confirmed by genetic tests.

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Men with more vanadium in their blood and who drink less soy milk are more likely to have hair loss.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Hormones like testosterone and estrogen significantly affect hair growth and structure.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

Three to five ovarian punctures are best for improving fertility in women with PCOS without harming the ovaries.